With over 16 years of experience in the pharmaceutical industry, Roxana is returning to Romania after nine years and after holding important roles in Sweden, Denmark, and Belgium, where she managed complex cross-functional teams and coordinated projects to support patients worldwide, according to Janssen officials.
“In 2023, Janssen Romania celebrates 30 years of medical innovation for patients in our country and throughout this time, we have been a constant partner in the development of the healthcare system. All of our efforts will continue to be directed towards ensuring a better environment for Romanian patients through access to medical innovation, open dialogue with Romanian authorities and healthcare professionals, as well as through our social involvement.” said Roxana Botea, Country Director for Janssen Romania.
Janssen’s portfolio covers six therapeutic areas in Romania, for a range of serious conditions in hematology, oncology, psychiatry and neuroscience, immunology, infectious diseases, cardiovascular and metabolic diseases, and pulmonary hypertension.